Journals / Ege Pediatri Bülteni / 2007 / Cilt: 14 - Sayı: 3

Cefaclor associated serum sickness-like reaction: A case report

Oral sefaklor tedavisinden sonra serum hastalığına benzer tablo gösteren bir olgu

Pages
183–185
Publication Date
2022-10-17
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

In this paper, a 30 month old previously healthy girl, who was referred to our hospital with fever, urticarial rash and joint manifestations and a diagnosis of cefaclor associated serum sickness-like reaction was established, was presented in order to emphasize relatively frequent cutaneous and joint manifestations of this drug

📌 3 Key Takeaways

🎯
Objective & Hypothesis:Cefaclor is an oral semi-synthetic broad-spectrum cephalosporin with a broad spectrum activity against both Gram positive and negative bacteria.
📊
Key Findings & Data:It is widely used in a range of pediatric infections including otitis media, tonsillitis and skin infections.
💡
Conclusion & Impact:In this paper, a 30 month old previously healthy girl, who was referred to our hospital with fever, urticarial rash and joint manifestations and a diagnosis of cefaclor associated serum sickness-like reaction was established, was presented in order to emphasize relatively frequent cutaneous and joint manifestations of this drug
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Domain Parameters

Abstract

Cefaclor is an oral semi-synthetic broad-spectrum cephalosporin with a broad spectrum activity against both Gram positive and negative bacteria. It is widely used in a range of pediatric infections including otitis media, tonsillitis and skin infections. However, there are increasing reports of cefaclor associated serum sickness-like reaction. In this paper, a 30 month old previously healthy girl, who was referred to our hospital with fever, urticarial rash and joint manifestations and a diagnosis of cefaclor associated serum sickness-like reaction was established, was presented in order to emphasize relatively frequent cutaneous and joint manifestations of this drug

Özet

Sefaklor hem gram pozitif hem de gram negatif etkisi olan geniş spektrumlu oral semisentetik bir sefalosporindir. Pediatrik yaş grubunda otitis media, tonsillit ve deri enfeksiyonları gibi enfeksiyonlarda sıkça kullanılmaktadır. Bununla birlikte, giderek artan sayıda hipersensitivite reaksiyonu bildirilmektedir. Bu yazıda, bu ilacın neden olduğu deri ve eklem bulgularını vurgulamak amacıyla, ürtiker ve artrit bulguları nedeniyle hastanemize sevk edilen ve sefaklor kullanımı ile ilişkili serum hastalığına benzer reaksiyon tanısı alan 30 aylık bir kız olgu sunulmuştur.

🔖

Cite This Article

AKŞİT, S., KARADENİZ, C., SERDAROĞLU, G., TÜRKOĞLU, E. (2022). Cefaclor associated serum sickness-like reaction: A case report. Ege Pediatri Bülteni, Cilt: 14 - Sayı: 3, 183–185. https://ajindex.com/articles/495708

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (1)

  1. Kammer RB. Cefaclor in maagement of sterptococcal pharyngitis, otitis media, and skin infections. Ann Otol Rhinol Laryngol. 1981;90:79-81 2. King BA,GC Geelhoed GC. Adverse skin and joint reactions associated with oral antibiotics in children: The role of cefaclor in serum sickness-like reactions J Paediatr Child Health 2003;39:677–81. 3. Murray DL. Singer DA, Singer A. Cefaclor – a cluster of adverse reactions. N Eng J Med. 1980;303:1003. 4. Hebert AA, Sigman ES, Levy ML. Serum sickness-like reactions from cefaclor in children. J. Am Acad Dermatol 1991;25 805–8. 5. Martin J, Abbott G. Serum sickness-like illness and antimicrobials in children.NZ Med J. 1995;108:123–4. 6. Vial T, Pont J, Pham E, Rabilloud M, Descotes J. Cefaclor associated serum sickness-like disease: eight cases and review of the literature. Ann Pharmacother 1992;26:910–13. 7. Parshuram CS, Phillips RJ. Retrospective review of antibioticassociated serum sickness in children presenting to a paediatric emergency department. Med. J Aust 1998;169:116. 8. Joubert GI, Hadad K, Matsui D, Gloor J, Rieder MJ. Selection of treatment of cefaclor-associated urticarial, serum sickness-like reactions and erythema multiforme by emergency pediatricians. Lack of a uniform standard of care. Can J Clin Pharmacol 1999;6:197–201. 9. Kearns GI, Wheeler JG, Chıldress SH, Letzig LG. Serum sickness-like reactions to cefaclor: Role of hepatic metabolism and individual sensitivity.J. Pediatr. 1994;125:805-11